Sign In
Buy OGN
$13.56
+0 (+0%)
At Close: Aug 04, 2026
Organon to Acquire Dermavant including its Innovative Dermatologic Therapy, VTAMA® (tapinarof) Cream, 1%
07:30am, Wednesday, 18'th Sep 2024
JERSEY CITY, N.J.--(BUSINESS WIRE)--Organon enters agreement to acquire Dermavant including innovative VTAMA (tapinarof) cream, 1%, a novel, non-steroidal topical dermatologic therapy.
Organon (OGN) Outperforms Broader Market: What You Need to Know
06:56pm, Friday, 13'th Sep 2024
Organon (OGN) concluded the recent trading session at $20.47, signifying a +0.89% move from its prior day's close.
Here is What to Know Beyond Why Organon & Co. (OGN) is a Trending Stock
10:00am, Thursday, 12'th Sep 2024
Recently, Zacks.com users have been paying close attention to Organon (OGN). This makes it worthwhile to examine what the stock has in store.
JP Morgan Shows Most Interest In Teva, Organon As Specialty Pharma Sector Exhibits Signs Of Stability
01:46pm, Friday, 06'th Sep 2024
JP Morgan notes that while there's a resurgence of interest and excitement in new product launches within the specialty group, including branded and complex generics/biosimilars, investors should be d
Is Trending Stock Organon & Co. (OGN) a Buy Now?
10:01am, Wednesday, 28'th Aug 2024
Zacks.com users have recently been watching Organon (OGN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Is Most-Watched Stock Organon & Co. (OGN) Worth Betting on Now?
10:02am, Wednesday, 14'th Aug 2024
Organon (OGN) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Organon (OGN) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
12:01pm, Tuesday, 06'th Aug 2024
Although the revenue and EPS for Organon (OGN) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street es
Organon (OGN) Surpasses Q2 Earnings Estimates
09:56am, Tuesday, 06'th Aug 2024
Organon (OGN) came out with quarterly earnings of $1.12 per share, beating the Zacks Consensus Estimate of $1.06 per share. This compares to earnings of $1.31 per share a year ago.
Top 4 stocks that could thrive if Kamala Harris wins the 2024 US election
07:45am, Saturday, 03'rd Aug 2024
As the 2024 US presidential election approaches, speculation about Kamala Harris potentially stepping into the Oval Office remains strong. Despite Donald Trump's assertion that Harris would be an ea
Product Demand Likely to Aid Organon's (OGN) Q2 Earnings
01:11pm, Friday, 02'nd Aug 2024
Continued solid uptake of Organon's (OGN) products is expected to have driven second-quarter revenues.
Seeking Clues to Organon (OGN) Q2 Earnings? A Peek Into Wall Street Projections for Key Metrics
10:20am, Thursday, 01'st Aug 2024
Besides Wall Street's top -and-bottom-line estimates for Organon (OGN), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the qua
Organon (OGN) Stock Falls Amid Market Uptick: What Investors Need to Know
06:51pm, Wednesday, 31'st Jul 2024
In the latest trading session, Organon (OGN) closed at $21.86, marking a -1.84% move from the previous day.
Earnings Preview: Organon (OGN) Q2 Earnings Expected to Decline
11:07am, Tuesday, 30'th Jul 2024
Organon (OGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Organon: Upcoming Q2 Earnings Can Sustain Upward Momentum
09:41pm, Monday, 29'th Jul 2024
Organon stock experienced significant downside pressure in 2023, however positive Q423 and Q124 earnings have led to a bull run. Organon's business includes women's health, biosimilars, and establishe
3 Medical Services Industry Stocks to Buy as Healthcare Wage Increases
11:11am, Friday, 26'th Jul 2024
The Zacks Medical - Services industry is growing on nursing care market growth and digital healthcare adoption. ICLR, OGN and DOCS are set to gain the most.
